GlassScriptPhysician profile
Mark A Monsour
NPI 1326156746
$9,631.31
in general payments reported to CMS, 2019-2025
55 companies · $1,161 in 2025
The $1,161 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,249 · 2020: $265 · 2021: $640 · 2022: $1,619 · 2023: $3,055 · 2024: $1,643 · 2025: $1,161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,631 · Travel and Lodging: $1,228.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,630.85 |
| Travel and Lodging | $1,227.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $1,598.80 | 2023-2025 | Aquabeam Robotic System, Aquabeam System |
| Janssen Biotech, INC. | $813.65 | 2019-2025 | Erleada, Akeega |
| Boston Scientific Corporation | $691.96 | 2020-2025 | Lithovue, Lithoclast, Spaceoar Vue System - 10ml |
| Astellas Pharma US INC | $677.08 | 2019-2023 | Myrbetriq |
| Janssen Scientific Affairs, LLC | $397.82 | 2019-2025 | Erleada, Pipeline, Balversa |
| Dornier Medtech America, INC | $384.06 | 2022-2023 | Dornier Medtech |
| Ferring Pharmaceuticals INC. | $326.15 | 2019-2025 | Adstiladrin |
| Progenics Pharmaceuticals, INC. | $325.47 | 2022-2024 | Pylarify |
| Teleflex LLC | $291.23 | 2021-2023 | Urolift |
| Sumitomo Pharma America, INC. | $282.94 | 2023-2025 | Orgovyx, Gemtesa |
| Dendreon Pharmaceuticals LLC | $262.46 | 2019-2025 | Provenge |
| Srs Medical Systems, INC. | $239.29 | 2022-2024 | Ct3000 Pro Base Unit, Urocuff-Dc Disposable, Single, Urocuff |
| Novartis Pharmaceuticals Corporation | $224.40 | 2022-2025 | |
| Pfizer INC. | $219.83 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $190.92 | 2020-2024 | Lynparza, Keytruda, Welireg |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $176.87 | 2021-2025 | Jelmyto |
| Bayer Healthcare Pharmaceuticals INC. | $158.71 | 2019-2025 | |
| Neotract INC. | $158.45 | 2019 | |
| Myovant Sciences INC. | $156.07 | 2021-2022 | |
| Alnylam Pharmaceuticals INC. | $146.97 | 2022 | |
| Coloplast Corp | $126.71 | 2019-2024 | |
| Rochester Medical Corporation | $122.24 | 2019-2022 | |
| Tolmar Pharmaceuticals, INC. | $109.33 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $106.60 | 2019-2024 | |
| Abbvie INC. | $95.88 | 2022-2025 | |
| Myriad Genetic Laboratories, INC. | $90.72 | 2021-2025 | Prolaris |
| Blue Earth Diagnostics | $90.35 | 2019-2022 | |
| C. R. Bard, INC. & Subsidiaries | $84.01 | 2024-2025 | Bard Urinary Drainage Bag, Magic3 Go Intermittent Urinary Catheter |
| Amgen INC. | $83.69 | 2019-2024 | Prolia |
| Edap Technomed INC | $78.60 | 2023-2024 | |
| Foundation Medicine, INC. | $75.27 | 2019-2023 | |
| 180 Medical, INC. | $67.51 | 2019-2024 | Cure Catheter |
| Urovant Sciences INC | $65.13 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $56.16 | 2019-2023 | Xiaflex, Aveed |
| Axonics, INC. | $53.51 | 2020-2023 | Axonics |
| Tempus Ai, INC | $50.57 | 2024-2025 | Xt Cdx |
| Genzyme Corporation | $48.17 | 2019-2023 | |
| Alexion Pharmaceuticals, INC. | $46.38 | 2023-2025 | Ultomiris |
| Hollister Incorporated | $42.86 | 2023 | Vapro, Infyna Chic |
| Laborie Medical Technologies Corp. | $42.32 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Verity Pharmaceuticals INC. | $39.61 | 2024-2025 | Tlando, Trelstar |
| Endo USA, INC. | $36.56 | 2025 | Xiaflex |
| Convatec INC. | $35.80 | 2022 | |
| Antares Pharma, INC. | $35.25 | 2022 | |
| Tolmar, INC. | $33.72 | 2023-2024 | |
| Astrazeneca Pharmaceuticals LP | $30.96 | 2021 | |
| Caris Mpi, INC. | $29.12 | 2025 | Mi Cancer Seek |
| Karl Storz Endoscopy-America | $24.90 | 2023 | Flex-X |
| Photocure INC | $24.00 | 2022 | |
| Kerecis Limited | $21.38 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Accord Healthcare, INC. | $18.39 | 2023 | |
| Koelis INC. | $15.93 | 2023 | |
| Olympus America INC. | $15.26 | 2023 | Oes Cystonephrofiberscope |
| Allergan, INC. | $11.29 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$986.22 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Monsour listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.